RELAPSED/REFRACTORY MULTIPLE MYELOMA
Clinical trials for RELAPSED/REFRACTORY MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat myeloma
Disease control TerminatedThis study tested a combination of four drugs (daratumumab, ixazomib, pomalidomide, and dexamethasone) in 23 people with multiple myeloma that had returned or stopped responding to earlier treatments. The goal was to see how many patients responded and to check for side effects. …
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Experimental myeloma drug trial halted early: what we know
Disease control TerminatedThis study tested an experimental drug called AMG 701, alone or with other medicines, in 174 adults with multiple myeloma that had come back or stopped responding to prior treatments. The main goals were to check safety and find the best dose. The trial was stopped early, so resu…
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated May 12, 2026 13:40 UTC